SCHEMBL1269603

SCHEMBL1269603

O=C(c1cc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2Cl)ncc1Sc1ccc(S(=O)(=O)N2CCOCC2)cc1)C1CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.45
▸ PKM P14618 1/20 0.45
▸ EPHX2 P34913 2/20 0.41
▸ CCR6 P51684 3/20 0.39
▸ HTT P42858 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ IDH2 P48735 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ PIK3C3 Q8NEB9 1/20 0.38
▸ CCKBR P32239 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269770 0.86 GAA (0.42) GAAPKMEPHX2HTTIDH2
SCHEMBL1268492 0.86 GAA (0.45) GAAPKMEPHX2HTTL3MBTL1
SCHEMBL12900168 0.85 GAA (0.48) GAAPKMEPHX2CCR6HTT
SCHEMBL1268959 0.83 ALDH1A1 (0.43) GAAHTTMAPTLMNAKDM4E
SCHEMBL1268685 0.80 GAA (0.43) GAAPKMEPHX2HTTSCN9A
SCHEMBL1269953 0.79 CCKBR (0.42) GAAEPHX2CCR6L3MBTL1PIK3C3
SCHEMBL1269704 0.79 GAA (0.46) GAAPKMEPHX2HTTSCN9A
SCHEMBL1268674 0.79 GAA (0.42) GAAPKMEPHX2HTTL3MBTL1
SCHEMBL1269628 0.79 CCKBR (0.43) GAAEPHX2CCR6HTTL3MBTL1
SCHEMBL1269747 0.78 ALDH1A1 (0.42) GAACCR6HTTL3MBTL1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
EP-1786782-A2 BISARYL-SULFONAMIDES Amgen Inc. (US) 2007-05-23 — — EP disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed
WO-2006020830-A2 BISARYL-SULFONAMIDES AMGEN INC. (US) 2006-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG GAA 1704/4885PKM 3049/4885EPHX2 1942/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG GAA 1704/4885PKM 3049/4885EPHX2 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback